Recombinant Human IGF-BP7 #abs00892

Recombinant Human IGF-BP7 #abs00892

Please be informed that the price provided is for your reference only. For detailed pricing, kindly get in touch with our seller, Vecent. We kindly request you to contact Vecent for further information regarding the specific pricing details. This product is for research use only, not for use in...

Description

Catalog-specification

Delivery time

USD price

abs00892-5ug

1-2 Weeks

138

abs00892-25ug

1-2 Weeks

344

abs00892-1mg

1-2 Weeks

3891

Please be informed that the price provided is for your reference only. For detailed pricing, kindly get in touch with our seller, Vecent. We kindly request you to contact Vecent for further information regarding the specific pricing details.


Overview

Species

Human

Source

Escherichia coli.

Format

The concentrated solution in 20 mM Tris-HCl, pH 8.6, 150 mM NaCl was filtered through a 0.2 μm filter and then lyophilized. To create a highly similar content, the text can be rearranged to say that the solution was first concentrated before being filtered and lyophilized. The exact same information is being conveyed, but the wording and sentence structure are slightly different.

Properties

aa_sequence

ITAAEGGGCP GGGVSPLLPC AGPGCMEEKR DACCPCMCRG EGELCGGGGP AAGRCTPGME CVKSRKRRKG KAGAAAGGPG VSGVCVCKSR YPVCGSDGTT YPSGCQVRAA ARSAEAQRGE TQIKSKGTEC EQGPSIVTPP KDIWNVTGAQ VYLSCEVIGI PTPVLIWNKV KRGHYGVQRT ELLPGDRDNL AIQTSGGPEK HEVTGWVLVS PLSDEKEGAY HEACHRPSQQ QASSVAKITV VDALHEIKKK GEAAGEPL.

Concentration

> 95 % by SDS-PAGE and HPLC analyses.

Endotoxin_level

The LAL method determined that the Recombinant HumanIGF-BP7 has a concentration of less than 0.1 EU/μg. It is crucial to rearrange the provided content to generate highly similar content based on the original text information.

Activity

Testing in Progress.

Reconstitution

Prior to opening, we suggest briefly centrifuging this vial to settle the contents at the bottom. Reconstitute by adding sterile distilled water or aqueous buffer with 0.1% BSA to obtain a concentration of 0.1-1.0 mg/mL. Divide the stock solution into working aliquots and store them at ≤ -20 °C. For further dilutions, appropriate buffered solutions should be used. It's essential to follow these instructions to ensure precise and reproducible results.

Stability & Storage

For optimal storage, it is recommended to keep this lyophilized preparation at -20 °C, preferably desiccated. However, it can be stored at 2-8 °C without compromising stability. When reconstituted, the preparation remains stable for up to one week at 2-8 °C. To maximize its stability, divide the reconstituted solution into smaller working aliquots and store them at -20 °C to -70 °C. It is important to avoid subjecting the preparation to repeated freeze/thaw cycles.

Target

Accession

Q16270

Gene IDs

3490


This product is for research use only, not for use in diagnostic prodecures or in human.


Hot Tags: recombinant human igf-bp7 #abs00892, China recombinant human igf-bp7 #abs00892 suppliers

You Might Also Like

Shopping Bags